Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    November 2022
  1. SHENOY-BHANGLE AS, Gee MS
    CT Versus MR Enterography: Counterpoint-MR Enterography Is the Primary Imaging Modality for Assessing Activity and Therapeutic Response in Pediatric and Adult Crohn Disease.
    AJR Am J Roentgenol. 2022 Nov 23. doi: 10.2214/AJR.22.28778.
    PubMed    


  2. THOMAS SP, Jaffe TA
    CT Versus MR Enterography: Point-CT Enterography Remains Essential to Imaging Patients With Inflammatory Bowel Disease in the Acute Setting.
    AJR Am J Roentgenol. 2022 Nov 23. doi: 10.2214/AJR.22.28716.
    PubMed    


    August 2022
  3. RICHER EJ
    Editorial Comment: Utility of an Image-Based Scoring System in Assessment of Pediatric Small-Bowel Crohn Disease.
    AJR Am J Roentgenol. 2022 Aug 31. doi: 10.2214/AJR.22.28408.
    PubMed    


  4. DILLMAN JR, Ata NA, Towbin AJ, Anton CG, et al
    The Simplified MR Index of Activity Score in Pediatric Small Bowel Crohn Disease: An Interreader Agreement and Responsiveness Study.
    AJR Am J Roentgenol. 2022 Aug 10. doi: 10.2214/AJR.22.28123.
    PubMed     Abstract available


    June 2022
  5. ANUPINDI SA
    Editorial Comment: MRI-Based Assessment of Intestinal Motility in Children and Young Adults With Newly Diagnosed Crohn Disease Before and After Biologic Treatment.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.28020.
    PubMed    


    May 2022
  6. DILLMAN JR, Tkach JA, Imbus R, Towbin AJ, et al
    MRI-Based Characterization of Intestinal Motility in Children and Young Adults With Newly Diagnosed Ileal Crohn Disease Treated by Biologic Therapy: A Controlled Prospective Study.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27792.
    PubMed     Abstract available


    March 2022
  7. NOGA M
    Editorial Comment: Velocity-Encoded Phase Contrast MRI Based Mesenteric Blood Flow Measurement Is a Promising Technique for Assessing Inflammation in Ileal Crohn Disease.
    AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27593.
    PubMed    


    February 2022
  8. ATA NA, Dillman JR, Gandhi D, Dudley JA, et al
    Velocity-Encoded Phase Contrast MRI for Measuring Mesenteric Blood Flow in Patients with Newly Diagnosed Small Bowel Crohn Disease.
    AJR Am J Roentgenol. 2022 Feb 23. doi: 10.2214/AJR.22.27437.
    PubMed     Abstract available


    November 2021
  9. KIM J, Seo N, Bae H, Kang EA, et al
    Comparison of Sensitivity Encoding (SENSE) and Compressed Sensing-SENSE for Contrast-Enhanced T1-Weighted Imaging in Patients With Crohn Disease Undergoing MR Enterography.
    AJR Am J Roentgenol. 2021 Nov 3. doi: 10.2214/AJR.21.26733.
    PubMed     Abstract available


    October 2021
  10. ANUPINDI SA, Kim MJ, Kljucevsek D, Watson TA, et al
    The Global Reading Room: Imaging of Suspected Pediatric Crohn Disease.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26977.
    PubMed    


  11. PARODER V
    Editorial Comment: Continuously Expanding Impact of MRI in Management of Perianal Crohn Disease.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26937.
    PubMed    


    September 2021
  12. GREER MC, Taylor SA
    Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of Inflammation.
    AJR Am J Roentgenol. 2021 Sep 22. doi: 10.2214/AJR.21.26615.
    PubMed     Abstract available


    December 2020
  13. JHAVERI KS, Sagheb S, Guimaraes L, Krishna S, et al
    Evaluation of Crohn Disease Activity Using a Potential Abbreviated MRE Protocol Consisting of Balanced Steady-State Free Precession MRI Only Versus Full-Protocol MRE.
    AJR Am J Roentgenol. 2020 Dec 9:1-9. doi: 10.2214/AJR.20.22856.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: